H18.533

Clinical Causes: Genetic mutations: The primary cause of granular corneal dystrophy is inherited genetic mutations affecting the TGFBI gene. Inheritance pattern: It follows an autosomal dominant inheritance pattern, meaning a single copy of the altered gene from an affected parent can cause the disorder. No known environmental factors: The development is purely genetic, with no proven link to environmental exposures or lifestyle choices.

Key Symptoms: Gradual clouding or opacity in the cornea, often appearing as small, white to yellowish granular deposits. Decreased visual acuity, leading to blurred or hazy vision. Light sensitivity or glare, especially in bright conditions. Potential recurrent corneal erosions, causing discomfort or pain. Possible recurrent episodes of blurred vision or visual disturbances as deposits increase.

Diagnosis Path: Diagnosis usually involves a comprehensive eye examination, including slit-lamp biomicroscopy to observe corneal deposits. Doctors may also perform corneal imaging and genetic testing to confirm the presence of specific mutations. The characteristic appearance of the deposits often supports a clinical diagnosis, but genetic testing can provide definitive confirmation, especially in uncertain cases.

Treatment Protocols: Observation: Mild cases may only require regular monitoring without active treatment. Corneal transplantation: In advanced cases where vision is severely impaired, procedures such as superficial keratectomy or lamellar keratoplasty can remove the deposits and improve visual clarity. Phototherapeutic keratectomy (PTK): A laser procedure used to precisely remove superficial corneal deposits. Use of corrective lenses or glasses to improve vision if needed. Managing recurrent erosions: Use of lubricating eye drops or ointments to prevent corneal damage. Research and experimental treatments: Ongoing studies are investigating potential gene therapies and other novel approaches.